Slingshot members are tracking this event:

Cytokinetics Announces Start of Phase 1b Clinical Trial of CK-2127107 in Elderly Subjects With Limited Mobility

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
CYTK Community voting in process
ALPMY Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 29, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Ck-2127107, Physical Function